SEARCH

SEARCH BY CITATION

Literature cited

  • Adjuik, M., A. Babiker, P. Garner, P. Olliaro, W. Taylor, and N. White. 2004. Artesunate combinations for treatment of malaria: meta-analysis. Lancet 363:917.
  • Ashley, E. A., and N. J. White. 2005. Artemisinin-based combinations. Current Opinion in Infectious Diseases 18:531536.
  • Barnes, K. I., and N. J. White. 2005. Population biology and antimalarial resistance: the transmission of antimalarial drug resistance in Plasmodium falciparum. Acta Tropica 94:230240.
  • Boni, M. F., C. O. Buckee, and N. J. White. 2008a. Mathematical models for a new era of malaria eradication. PLoS Medicine 5:e231.
  • Boni, M. F., D. L. Smith, and R. Laxminarayan. 2008b. Benefits of using multiple first-line therapies against malaria. Proceedings of the National Academy of Sciences of the United States of America 105:1421614221.
  • Buckling, A. G., L. H. Taylor, J. M. Carlton, and A. F. Read. 1997. Adaptive changes in Plasmodium transmission strategies following chloroquine chemotherapy. Proceedings. Biological Sciences 264:553559.
  • Cross, A. P., and B. Singer. 1991. Modelling the development of resistance of Plasmodium falciparum to anti-malarial drugs. Transactions of the Royal Society of Tropical Medicine and Hygiene 85:349355.
  • Curtis, C. F., and L. N. Otoo. 1986. A simple model of the build-up of resistance to mixtures of anti-malarial drugs. Transactions of the Royal Society of Tropical Medicine and Hygiene 80:889892.
  • Dondorp, A., F. Nosten, K. Stepniewska, N. Day, and N. White. 2005. Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial. Lancet 366:717725.
  • Dye, C., and B. G. Williams. 1997. Multigenic drug resistance among inbred malaria parasites. Proceedings of the Royal Society of London. Series B: Biological Sciences 264:6167.
  • Gatton, M. L., W. Hogarth, and A. Saul. 2001. Time of treatment influences the appearance of drug-resistant parasites in Plasmodium falciparum infections. Parasitology 123:537546.
  • Hastings, I. M. 1997. A model for the origins and spread of drug-resistant malaria. Parasitology 115:133141.
  • Hastings, I. M. 2004. The origins of antimalarial drug resistance. Trends in Parasitology 20:512518.
  • Hastings, I. M., and W. M. Watkins. 2005. Intensity of malaria transmission and the evolution of drug resistance. Acta Tropica 94:218229.
  • Hastings, I. M., P. G. Bray, and S. A. Ward. 2002a. Parasitology. A requiem for chloroquine. Science 298:7475.
  • Hastings, I. M., W. M. Watkins, and N. J. White. 2002b. The evolution of drug-resistant malaria: the role of drug elimination half-life. Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences 357:505519.
  • Hutagalung, R., H. Htoo, P. Nwee, J. Arunkamomkiri, J. Zwang, V. I. Carrara, E. Ashley et al. 2006. A case-control auditory evaluation of patients treated with artemether-lumefantrine. American Journal of Tropical Medicine and Hygiene 74:211214.
  • Hyde, J. E. 2002. Mechanisms of resistance of Plasmodium falciparum to antimalarial drugs. Microbes and Infection 4:165174.
  • Institute of Medicine. 2004. Saving Lives, Buying Time: Economics of Malaria Drugs in an Age of Resistance. The National Academies Press, Washington, DC.
  • Koella, J. C., and R. Antia. 2003. Epidemiological models for the spread of anti-malarial resistance. Malaria Journal 2:3.
  • Levin, B. R. 2002. Models for the spread of resistant pathogens. Netherlands Journal of Medicine 60:5864.
  • Newton, P. N., B. J. Angus, W. Chierakul, A. Dondorp, R. Ruangveerayuth, K. Silamut, P. Teerapong et al. 2003. Randomized comparison of artesunate and quinine in the treatment of severe falciparum malaria. Clinical Infectious Diseases 37:716.
  • Paget-McNicol, S., and A. Saul. 2001. Mutation rates in the dihydrofolate reductase gene of Plasmodium falciparum. Parasitology 122:497505.
  • Pongtavornpinyo, W. 2006. Mathematical modelling of antimalarial drug resistance. PhD Dissertation. Liverpool School of Tropical Medicine. Liverpool.
  • Price, R. N., F. Nosten, J. A. Simpson, C. Luxemburger, L. Phaipun, F. Ter Kuile, M. Van Vugt et al. 1999. Risk factors for gametocyte carriage in uncomplicated falciparum malaria. American Journal of Tropical Medicine and Hygiene 60:10191023.
  • Sibley, C. H., J. E. Hyde, P. F. Sims, C. V. Plowe, J. G. Kublin, E. K. Mberu, A. F. Cowman et al. 2001. Pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: what next? Trends in Parasitology 17:582588.
  • Smithuis, F., M. K. Kyaw, O. Phe, K. Z. Aye, L. Htet, M. Barends, N. Lindegardh et al. 2006. Efficacy and effectiveness of dihydroartemisinin-piperaquine versus artesunate-mefloquine in falciparum malaria: an open-label randomised comparison. Lancet 367:20752085.
  • Stepniewska, K., and N. J. White. 2008. Pharmacokinetic determinants of the window of selection for antimalarial drug resistance. Antimicrobial Agents and Chemotherapy 52:15891596.
  • Watkins, W. M., and M. Mosobo. 1993. Treatment of Plasmodium falciparum malaria with pyrimethamine-sulfadoxine: selective pressure for resistance is a function of long elimination half-life. Transactions of the Royal Society of Tropical Medicine and Hygiene 87:7578.
  • White, N. J. 2008. Qinghaosu (artemisinin): the price of success. Science 320:330334.
  • White, N. J., and W. Pongtavornpinyo. 2003. The de novo selection of drug-resistant malaria parasites. Proceedings of the Royal Society of London. Series B: Biological Sciences 270:545554.
  • White, N. J., D. Chapman, and G. Watt. 1992. The effects of multiplication and synchronicity on the vascular distribution of parasites in falciparum malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene 86:590597.
  • World Health Organisation (WHO). 2006. Guidelines for the Treatment of Malaria. WHO, Geneva, Switzerland.
  • Yeung, S., W. Pongtavornpinyo, I. M. Hastings, A. J. Mills, and N. J. White. 2004. Antimalarial drug resistance, artemisinin-based combination therapy, and the contribution of modeling to elucidating policy choices. American Journal of Tropical Medicine and Hygiene 71:179186.